Collect. Czech. Chem. Commun.
2010, 75, 81-103
https://doi.org/10.1135/cccc2009087
Published online 2010-02-08 13:58:03
Therapeutic targets for influenza – perspectives in drug development
Taťána Majerováa,b,*, Hillary Hoffmana,b and Filip Majerc
a Department of Biochemistry, Faculty of Natural Sciences, Charles University in Prague, Hlavova 2030, 128 43 Prague 2, Czech Republic
b Joint Research Centre of Gilead Sciences and Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
c Institute of Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University in Prague, Ke Karlovu 2, 128 00 Prague 2, Czech Republic
Crossref Cited-by Linking
- Majerová Taťána, Konvalinka Jan: Viral proteases as therapeutic targets. Molecular Aspects of Medicine 2022, 88, 101159. <https://doi.org/10.1016/j.mam.2022.101159>
- Majerová Taťána, Novotný Pavel: Precursors of Viral Proteases as Distinct Drug Targets. Viruses 2021, 13, 1981. <https://doi.org/10.3390/v13101981>
- Majerová Taťána, Novotný Pavel, Krýsová Eliška, Konvalinka Jan: Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Biochimie 2019, 166, 132. <https://doi.org/10.1016/j.biochi.2019.05.004>
